Mapping the Relationship of White Matter Lesions to Depression in Multiple Sclerosis
Authors:
Open Access
- 17 November 2023
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 95 (12) , 1072-1080
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS112274)
- National Institute of Neurological Disorders and Stroke (R01NS085211)
- National Institute of Mental Health (R01MH120482)
- National Institute of Mental Health (K99MH127293)
- National Institute of Mental Health (R01MH123550)
- National Institute of Mental Health (K23MH133118)
- National Institute of Mental Health (R01MH112847)
- National Institute of Mental Health (R01MH113550)
- National Institute of Mental Health (T32MH019112)
- National Institute on Aging (R21 AG070434)
- National Institutes of Health
- American Medical Association
- National Multiple Sclerosis Society
- Brain and Behavior Research Foundation (31319)
This publication has 56 references indexed in Scilit:
- Network localization of neurological symptoms from focal brain lesionsBrain, 2015
- The link between multiple sclerosis and depressionNature Reviews Neurology, 2014
- Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis.Rehabilitation Psychology, 2014
- Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosisBMC Neurology, 2014
- Statistical normalization techniques for magnetic resonance imagingNeuroImage: Clinical, 2014
- Multiple sclerosis and depressionMultiple Sclerosis Journal, 2011
- Unbiased nonlinear average age-appropriate brain templates from birth to adulthoodNeuroImage, 2009
- Multiple sclerosisThe Lancet, 2008
- Screening for Depression in Medical Settings with the Patient Health Questionnaire (PHQ): A Diagnostic Meta-AnalysisJournal of General Internal Medicine, 2007
- Psychiatric side effects of interferon-β in multiple sclerosisEuropean Psychiatry, 2006